Teva Pharmaceutical Industries Limited
TEVA
$33.92
-$0.39-1.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.56B | 2.20B | 2.16B | 1.70B | 3.30B |
| Total Receivables | 3.71B | 3.81B | 3.56B | 3.38B | 3.06B |
| Inventory | 3.18B | 3.32B | 3.50B | 3.25B | 3.01B |
| Prepaid Expenses | 1.12B | 1.12B | 1.08B | 1.02B | 1.01B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.38B | 2.29B | 2.31B | 2.18B | 2.18B |
| Total Current Assets | 13.95B | 12.74B | 12.62B | 11.53B | 12.55B |
|
|
|||||
| Total Current Assets | 13.95B | 12.74B | 12.62B | 11.53B | 12.55B |
| Net Property, Plant & Equipment | 4.43B | 5.16B | 5.17B | 4.99B | 4.95B |
| Long-term Investments | 16.00B | 15.95B | 15.95B | 15.48B | 15.15B |
| Goodwill | 16.00B | 15.95B | 15.95B | 15.48B | 15.15B |
| Total Other Intangibles | 3.78B | 3.94B | 4.14B | 4.19B | 4.42B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.60B | 2.08B | 2.25B | 2.23B | 2.26B |
| Total Assets | 40.75B | 39.86B | 40.13B | 38.42B | 39.33B |
|
|
|||||
| Total Accounts Payable | 2.53B | 2.36B | 2.50B | 2.29B | 2.20B |
| Total Accrued Expenses | 6.08B | 6.22B | 6.05B | 5.71B | 5.65B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.91B | 24.00M | 464.00M | 421.00M | 1.87B |
| Total Finance Division Other Current Liabilities | 2.93B | 2.89B | 2.85B | 2.74B | 3.07B |
| Total Other Current Liabilities | 2.93B | 2.89B | 2.85B | 2.74B | 3.07B |
| Total Current Liabilities | 13.46B | 11.49B | 11.86B | 11.16B | 12.80B |
|
|
|||||
| Total Current Liabilities | 13.46B | 11.49B | 11.86B | 11.16B | 12.80B |
| Long-Term Debt | 15.01B | 16.78B | 16.78B | 16.23B | 16.00B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 311.00M | 283.00M | 296.00M | 288.00M | 314.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.06B | 4.04B | 4.36B | 4.47B | 4.49B |
| Total Liabilities | 32.83B | 32.60B | 33.30B | 32.15B | 33.61B |
|
|
|||||
| Common Stock & APIC | 28.19B | 28.10B | 28.06B | 28.02B | 27.82B |
| Retained Earnings | -13.76B | -14.24B | -14.68B | -14.96B | -15.17B |
| Treasury Stock & Other | -6.52B | -6.60B | -6.56B | -6.80B | -7.28B |
| Total Common Equity | 7.91B | 7.25B | 6.83B | 6.26B | 5.37B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.91B | 7.25B | 6.83B | 6.26B | 5.37B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 4.00M | 4.00M | 7.00M | 7.00M | 347.00M |
| Total Equity | 7.91B | 7.25B | 6.83B | 6.27B | 5.72B |
|
|
|||||